Ledermann, JA;
(2022)
Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib?
Gynecologic Oncology
, 164
(2)
pp. 243-244.
10.1016/j.ygyno.2022.01.018.
Preview |
Text
Ledermann_GYN-Onc Veliparib Editorial V3b 4-1-22.pdf Download (130kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Testing for homologous recombination deficiency – does it provide new insights for the use of veliparib? |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ygyno.2022.01.018 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10143081 |
Downloads since deposit
63Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
